CN Patent

CN113493490B — 一种合成肽酰胺类化合物及其在医药领域的用途

Assigned to Chengdu Nuohe Shengtai Biotechnology Co ltd · Expires 2024-03-12 · 2y expired

What this patent protects

本发明公开了一种多肽类衍生物，属于医药领域，具体涉及到一种含有硼酸基团的多肽类衍生物及其制备方法，并且公开了其在预防和治疗由κ阿片样物质受体引起的各种疾病的药物中的用途。

USPTO Abstract

本发明公开了一种多肽类衍生物，属于医药领域，具体涉及到一种含有硼酸基团的多肽类衍生物及其制备方法，并且公开了其在预防和治疗由κ阿片样物质受体引起的各种疾病的药物中的用途。

Drugs covered by this patent

difelikefalin-acetate (DIFELIKEFALIN ACETATE)

Patent Metadata

Patent number: CN113493490B
Jurisdiction: CN
Classification: —
Expires: 2024-03-12
Drug substance claim: No
Drug product claim: No
Assignee: Chengdu Nuohe Shengtai Biotechnology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.